Catalent
$59.95
24H
Market Cap
Volume
Supply
Price Chart
About Catalent - CTLT
Catalent, Inc. is a global provider of delivery technologies and development solutions for drugs, biologics, and consumer health products, known for its expertise in formulations, including softgel technologies, as well as bio-manufacturing and gene therapies. It works with pharmaceutical, biotech, and consumer health companies to bring treatments to market.
What are Catalent's core values and mission statement?
Catalent, Inc.'s mission centers on offering integrated services, superior delivery technologies, and manufacturing solutions to help its customers get their products to market faster. Core values of Catalent typically gravitate around patient focus, innovation, integrity, collaboration, and excellence, reflecting their commitment to delivering better treatments to improve patient lives.
Who founded Catalent and when?
Catalent, Inc. was not founded by a single individual; rather, it was created as a result of the acquisition of Cardinal Health's Pharmaceutical Technologies and Services segment by the private equity firm The Blackstone Group in 2007.
Who leads Catalent?
As of the latest available information, John Chiminski serves as the Chairman and Chief Executive Officer of Catalent, Inc. Please note that executive leadership positions can change, and it's advisable to check the latest company reports or official announcements for the most current information.
Where is Catalent located, and what is its base country?
Catalent, Inc. is headquartered in Somerset, New Jersey, United States.
On which exchanges is Catalent traded?
Catalent, Inc. is traded on the New York Stock Exchange (NYSE) under the ticker symbol CTLT.
Historical data
Catalent (CTLT) Price Live Data
The live price of Catalent (CTLT) is $59.95, with a trading volume of 1,308,358 in the last 24 hours. Wrapstocks updates the CTLT price in real-time. Catalent is down -0.01% in the last 24 hours. The company has a live market cap of $10,880,737,280.00 and a supply of 181,512,007 CTLT stocks.
Catalent (CTLT) is traded on New York Stock Exchange, and currently, the market is closed; trading will be resumed in 8 hours and 8 minutes.